Pomalidomide-C5-Dovitinib
Product Specifications
UNSPSC Description
Pomalidomide-C5-Dovitinib (compound 2) is a PROTAC containing Pomalidomide, Dovitinib and connected with CRBN. Pomalidomide-C5-Dovitinib shows enhanced antiproliferative effects against FLT3-ITD+ AML cells. Pomalidomide-C5-Dovitinib induces the degradation of the FLT3-ITD and KIT proteins in a ubiquitin-proteasome-dependent manner and completely blocks their downstream signaling pathway. Pomalidomide-C5-Dovitinib has the potential for the research of FLT3-ITD+ acute myeloid leukemia[1].
Target Antigen
Apoptosis; c-Fms; c-Kit; FGFR; FLT3; PDGFR; PROTACs; VEGFR
Type
Reference compound
Related Pathways
Apoptosis;PROTAC;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pomalidomide-c5-dovitinib.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(C(N)=C1C3=NC4=CC=C(N5CCN(CC5)C(CCCCCNC6=CC=CC(C(N7C8C(NC(CC8)=O)=O)=O)=C6C7=O)=O)C=C4N3)C(F)=CC=C2
Molecular Weight
747.77
References & Citations
[1]Cao S, et al. Proteolysis-Targeting Chimera (PROTAC) Modification of Dovitinib Enhances the Antiproliferative Effect against FLT3-ITD-Positive Acute Myeloid Leukemia Cells. J Med Chem. 2021;64(22):16497-16511.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139996/Pomalidomide-C5-Dovitinib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139996/
Clinical Information
No Development Reported
CAS Number
2732969-67-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1435796-01 0.02 mg (E-Coli)
Recombinant Pongo abelii PHD finger protein 6 (PHF6)
Ask
View Details